ABHD12

gene product
ABHD12A, BEM46L2, C20orf22, dJ965G21.2, DKFZP434P106
This gene encodes an enzyme that catalyzes the hydrolysis of 2-arachidonoyl glycerol (2-AG), the main endocannabinoid lipid transmitter that acts on cannabinoid receptors, CB1 and CB2. The endocannabinoid system is involved in a wide range of physiological processes, including neurotransmission, mood, appetite, pain appreciation, addiction behavior, and inflammation. Mutations in this gene are associated with the neurodegenerative disease, PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract), resulting from an inborn error of endocannabinoid metabolism. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2011]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Reference

Provider

Host

Reactivity

Antibody type

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
30 antibodies from 13 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELIFIPIHFC
GeneTex
3 antibodies
Aviva Systems Biology
4 antibodies
Abnova Corporation
2 antibodies
Novus Biologicals
6 antibodies
Acris Antibodies GmbH
1 antibody
Epitomics
1 antibody
antibodies-online
4 antibodies
Atlas Antibodies
1 antibody
Thermo Fisher Scientific Pierce
1 antibody
Everest Biotech
1 antibody
Sigma-Aldrich
3 antibodies
LifeSpan BioSciences, Inc.
2 antibodies
Creative Biomart
1 antibody